SCHEMBL5162964

SCHEMBL5162964

NC(=O)c1cccc(OC(C(=O)Nc2ccc(N3CCNCC3=O)cc2)c2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 10/20 0.53
PRSS1 P07477 5/20 0.53
SMN1; SMN2 Q16637 3/20 0.43
KMT2A Q03164 3/20 0.43
MAPKAPK2 P49137 1/20 0.41
SLC6A4 P31645 1/20 0.40
POLB P06746 1/20 0.40
F2 P00734 1/20 0.40
F9 P00740 1/20 0.38
PLAU P00749 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
GLA P06280 1/20 0.38
PKM P14618 1/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5166657 0.93 F10 (0.63) F10PRSS1MAPKAPK2F2F9
SCHEMBL5165480 0.85 F10 (0.63) F10PRSS1SMN1; SMN2KMT2AF9
SCHEMBL5164792 0.85 F10 (0.62) F10PRSS1SMN1; SMN2KMT2AF9
SCHEMBL5164062 0.79 F10 (0.69) F10PRSS1SMN1; SMN2KMT2AF2
SCHEMBL14408297 0.79 F10 (0.50) F10PRSS1SMN1; SMN2KMT2APOLB
SCHEMBL5164409 0.79 F10 (0.73) F10PRSS1SMN1; SMN2KMT2AF2
SCHEMBL5163848 0.78 F10 (0.55) F10PRSS1SMN1; SMN2KMT2APOLB
SCHEMBL5164956 0.78 F10 (0.59) F10PRSS1SMN1; SMN2KMT2APOLB
SCHEMBL14408268 0.78 F10 (0.60) F10PRSS1SMN1; SMN2KMT2APOLB
SCHEMBL5165542 0.78 F10 (0.46) F10PRSS1KMT2AMAPKAPK2F9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US claimed
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP claimed
US-20040087582-A1 Phenyl derivatives MERCK PATENT GESELLSCHAFT (DE) 2004-05-06 US claimed
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US disclosed
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP disclosed
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP disclosed
US-20040087582-A1 Phenyl derivatives MERCK PATENT GESELLSCHAFT (DE) 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087582-A1 Phenyl derivatives F2, F11, SERPINC1 F10 6/4885PRSS1 88/4885SMN1; SMN2 3430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.